BackImugene Limited Overview

Imugene Limited Profit Margin

Latest profit margin for Imugene Limited: -3963.47% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

N/A

As of Jun 2026

Annual Profit Margin (TTM)

-3963.47%
↓ 253.82% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Imugene Limited (IMU.AX) FAQ

Imugene Limited posts a profit margin of -3963.47% as of June 2026. That compares with -1120.18% in the prior-year period — down 253.8% year over year. That is below the Healthcare sector average of 21.75%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Imugene Limited's profit margin was -1120.18%. The latest reading is -3963.47% — a 253.8% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 21.75% is typical. Imugene Limited's -3963.47% is lower that level. That is roughly 18325.5% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Imugene Limited's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -3963.47% as of June 2026; use YoY and peer views to separate noise from signal.

Context for IMU.AX's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 21.75%), and (3) consistency with growth and profitability. This page covers the first two; Imugene Limited's other metric pages and overview cover the third.

Questions & Answers